{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:02Z","timestamp":1786982762397,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"FFG","award":["881646"],"award-info":[{"award-number":["881646"]}]},{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40262-025-01578-1","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:48:06Z","timestamp":1760813286000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy Volunteers"],"prefix":"10.1007","volume":"65","author":[{"given":"Valentin","family":"al Jalali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"W\u00f6lfl-Duchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Partl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"Vcelar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Katinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawad","family":"Bashur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Schnidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-5878","authenticated-orcid":false,"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"1578_CR1","doi-asserted-by":"publisher","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20(7):1126\u201367. Epub 20131022. https:\/\/doi.org\/10.1089\/ars.2012.5149. PubMed PMID: 23991888; PubMed Central PMCID: PMCPMC3929010.","DOI":"10.1089\/ars.2012.5149"},{"issue":"1","key":"1578_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","volume":"26","author":"MK Demoruelle","year":"2014","unstructured":"Demoruelle MK, Deane KD, Holers VM. When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol. 2014;26(1):64\u201371. https:\/\/doi.org\/10.1097\/BOR.0000000000000017. (PubMed PMID: 24247116; PubMed Central PMCID: PMCPMC4033623).","journal-title":"Curr Opin Rheumatol"},{"key":"1578_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112906","author":"MY Henein","year":"2022","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232112906. (Epub 20221026. PubMed PMID: 36361701; PubMed Central PMCID: PMCPMC9658900).","journal-title":"Int J Mol Sci"},{"key":"1578_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104578","volume":"113","author":"MA Jonsjo","year":"2020","unstructured":"Jonsjo MA, Olsson GL, Wicksell RK, Alving K, Holmstrom L, Andreasson A. The role of low-grade inflammation in ME\/CFS (Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome) - associations with symptoms. Psychoneuroendocrinology. 2020;113:104578. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104578. (Epub20191226. PubMed PMID: 31901625).","journal-title":"Psychoneuroendocrinology"},{"key":"1578_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2018;4:575\u201390. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014. (Epub 20180906 PubMed PMID: 30406177; PubMed Central PMCID: PMCPMC6214864).","journal-title":"Alzheimers Dement (N Y)"},{"issue":"11","key":"1578_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603\u201316. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.006. (Epub 20100916. PubMed PMID: 20840865; PubMed Central PMCID: PMCPMC2990475).","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1578_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.013. (PubMed PMID: 35021057; PubMed Central PMCID: PMCPMC8773457).","journal-title":"Immunity"},{"issue":"4","key":"1578_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jaip.2024.02.004","volume":"12","author":"MC Tattersall","year":"2024","unstructured":"Tattersall MC, Jarjour NN, Busse PJ. Systemic inflammation in asthma: what are the risks and impacts outside the airway? J Allergy Clin Immunol Pract. 2024;12(4):849\u201362. https:\/\/doi.org\/10.1016\/j.jaip.2024.02.004. (Epub 20240212 PubMed PMID: 38355013; PubMed Central PMCID: PMCPMC11219096).","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1578_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267091","volume":"14","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Zhang M, Jiang D, Su Q, Shi J. The role of inflammation in autoimmune disease: a therapeutic target. Front Immunol. 2023;14:1267091. https:\/\/doi.org\/10.3389\/fimmu.2023.1267091. (Epub 20231004. PubMed PMID: 37859999; PubMed Central PMCID: PMCPMC10584158).","journal-title":"Front Immunol"},{"issue":"3c","key":"1578_CR10","doi-asserted-by":"publisher","first-page":"14s","DOI":"10.1016\/0002-9343(91)90279-7","volume":"91","author":"B Halliwell","year":"1991","unstructured":"Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991;91(3c):14s\u201322s. https:\/\/doi.org\/10.1016\/0002-9343(91)90279-7. (PubMed PMID: 1928205).","journal-title":"Am J Med"},{"issue":"1","key":"1578_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ijc.21685","volume":"119","author":"J Alexandre","year":"2006","unstructured":"Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer. 2006;119(1):41\u20138. https:\/\/doi.org\/10.1002\/ijc.21685. (PubMed PMID: 16450384).","journal-title":"Int J Cancer"},{"issue":"24","key":"1578_CR12","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1200\/JCO.2005.05.514","volume":"23","author":"I Bairati","year":"2005","unstructured":"Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol. 2005;23(24):5805\u201313. https:\/\/doi.org\/10.1200\/JCO.2005.05.514. (Epub 20050718. PubMed PMID: 16027437).","journal-title":"J Clin Oncol"},{"issue":"7","key":"1578_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579\u201391. https:\/\/doi.org\/10.1038\/nrd2803. (Epub 20090529. PubMed PMID: 19478820).","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"1578_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","volume":"20","author":"M Laforge","year":"2020","unstructured":"Laforge M, Elbim C, Fr\u00e8re C, H\u00e9madi M, Massaad C, Nuss P, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515\u20136. https:\/\/doi.org\/10.1038\/s41577-020-0407-1. (PubMed PMID: 32728221; PubMed Central PMCID: PMCPMC7388427).","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1578_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0891-5849(02)00905-x","volume":"33","author":"IN Zelko","year":"2002","unstructured":"Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33(3):337\u201349. https:\/\/doi.org\/10.1016\/s0891-5849(02)00905-x. (PubMed PMID: 12126755).","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1578_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00003088-199528010-00003","volume":"28","author":"G Jadot","year":"1995","unstructured":"Jadot G, Vaille A, Maldonado J, Vanelle P. Clinical pharmacokinetics and delivery of bovine superoxide dismutase. Clin Pharmacokinet. 1995;28(1):17\u201325. https:\/\/doi.org\/10.2165\/00003088-199528010-00003. (PubMed PMID: 7712659).","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1578_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5414\/cp201651","volume":"50","author":"G Schaller","year":"2012","unstructured":"Schaller G, Dittrich P, Felizeter M, Gouya G, Leuchten N, Kapiotis S, et al. Human pharmacokinetics of intravenous recombinant human Cu\/Zn superoxide dismutase. Int J Clin Pharmacol Ther. 2012;50(6):413\u20137. https:\/\/doi.org\/10.5414\/cp201651. (PubMed PMID: 22541746).","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1578_CR18","unstructured":"Administration UFaD. Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine Clinical Trials2007. https:\/\/www.fda.gov\/media\/73679\/download. Accessed 02 Apr 2025"},{"issue":"17","key":"1578_CR19","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/0006-2952(84)90692-0","volume":"33","author":"A Baret","year":"1984","unstructured":"Baret A, Jadot G, Michelson AM. Pharmacokinetic and anti-inflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species. Biochem Pharmacol. 1984;33(17):2755\u201360. https:\/\/doi.org\/10.1016\/0006-2952(84)90692-0. (PubMed PMID: 6466383).","journal-title":"Biochem Pharmacol"},{"key":"1578_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2147\/cia.S201250","volume":"14","author":"M Kozakiewicz","year":"2019","unstructured":"Kozakiewicz M, Kornatowski M, Krzywi\u0144ska O, K\u0119dziora-Kornatowska K. Changes in the blood antioxidant defense of advanced age people. Clin Interv Aging. 2019;14:763\u201371. https:\/\/doi.org\/10.2147\/cia.S201250. (Epub 20190501. PubMed PMID: 31118597; PubMed Central PMCID: PMCPMC6507109).","journal-title":"Clin Interv Aging"},{"issue":"1","key":"1578_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1109-z","volume":"19","author":"C Mao","year":"2019","unstructured":"Mao C, Yuan JQ, Lv YB, Gao X, Yin ZX, Kraus VB, et al. Associations between superoxide dismutase, malondialdehyde and all-cause mortality in older adults: a community-based cohort study. BMC Geriatr. 2019;19(1):104. https:\/\/doi.org\/10.1186\/s12877-019-1109-z. (Epub 20190415. PubMed PMID: 30987591; PubMed Central PMCID: PMCPMC6466801).","journal-title":"BMC Geriatr"},{"issue":"1","key":"1578_CR22","first-page":"59","volume":"16","author":"M Talke","year":"1984","unstructured":"Talke M. Intra-articular therapy with superoxide dismutase (orgotein) or cortisone in rheumatoid and arthritic inflammatory finger joint lesions. Handchir Mikrochir Plast Chir. 1984;16(1):59\u201363 (PubMed PMID: 6714820).","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"1578_CR23","first-page":"134","volume":"27","author":"B Mazi\u00e8res","year":"1991","unstructured":"Mazi\u00e8res B, Masquelier AM, Capron MH. A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followup. J Rheumatol Suppl. 1991;27:134\u20137 (PubMed PMID: 2027114).","journal-title":"J Rheumatol Suppl"},{"issue":"2","key":"1578_CR24","first-page":"212","volume":"4","author":"EC Huskisson","year":"1981","unstructured":"Huskisson EC, Scott J. Orgotein in osteoarthritis of the knee joint. Eur J Rheumatol Inflamm. 1981;4(2):212\u20138 (PubMed PMID: 7044788).","journal-title":"Eur J Rheumatol Inflamm"},{"issue":"8","key":"1578_CR25","first-page":"1199","volume":"33","author":"K Lund-Olesen","year":"1983","unstructured":"Lund-Olesen K, Menander-Huber KB. Intra-articular orgotein therapy in osteoarthritis of the knee. A double-blind, placebo-controlled trial. Arzneimittelforschung. 1983;33(8):1199\u2013203 (PubMed PMID: 6357204).","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"1578_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0002-9343(89)80154-8","volume":"87","author":"H McIlwain","year":"1989","unstructured":"McIlwain H, Silverfield JC, Cheatum DE, Poiley J, Taborn J, Ignaczak T, et al. Intra-articular orgotein in osteoarthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison. Am J Med. 1989;87(3):295\u2013300. https:\/\/doi.org\/10.1016\/s0002-9343(89)80154-8. (PubMed PMID: 2773967).","journal-title":"Am J Med"},{"issue":"2","key":"1578_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/03009748409100372","volume":"13","author":"W Gammer","year":"1984","unstructured":"Gammer W, Brob\u00e4ck LG. Clinical comparison of orgotein and methylprednisolone acetate in the treatment of osteoarthrosis of the knee joint. Scand J Rheumatol. 1984;13(2):108\u201312. https:\/\/doi.org\/10.3109\/03009748409100372. (PubMed PMID: 6377491).","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1578_CR28","first-page":"21","volume":"42","author":"U M\u00fcller","year":"1983","unstructured":"M\u00fcller U, Moll G. Treatment of epicondylitis with locally injected orgotein (double blind study). Z Rheumatol. 1983;42(1):21\u20134 (PubMed PMID: 6342295).","journal-title":"Z Rheumatol"},{"issue":"1","key":"1578_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0002-9343(83)91128-2","volume":"74","author":"KM Goebel","year":"1983","unstructured":"Goebel KM, Storck U. Effect of intra-articular orgotein versus a corticosteroid on rheumatoid arthritis of the knees. Am J Med. 1983;74(1):124\u20138. https:\/\/doi.org\/10.1016\/0002-9343(83)91128-2. (PubMed PMID: 6336891).","journal-title":"Am J Med"},{"key":"1578_CR30","volume-title":"An introduction to radiobiology","author":"AHW N","year":"1998","unstructured":"AHW N. An introduction to radiobiology. Chichester, UK: John Wiley and Sons Ltd; 1998."},{"key":"1578_CR31","volume-title":"Nuclear medicine radiation dosimetry","author":"BJ M","year":"2010","unstructured":"BJ M. Nuclear medicine radiation dosimetry. London: Springer-Verlag; 2010."},{"issue":"2","key":"1578_CR32","first-page":"198","volume":"19","author":"F Edsmyr","year":"1976","unstructured":"Edsmyr F, Huber W, Menander KB. Orgotein efficacy in ameliorating side effects due to radiation therapy. I. Double-blind, placebo-controlled trial in patients with bladder tumors. Curr Ther Res Clin Exp. 1976;19(2):198\u2013211 (PubMed PMID: 813958).","journal-title":"Curr Ther Res Clin Exp"},{"issue":"2","key":"1578_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/bf02081999","volume":"6","author":"H Marberger","year":"1974","unstructured":"Marberger H, Huber W, Bartsch G, Schulte T, Swoboda P. Orgotein: a new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int Urol Nephrol. 1974;6(2):61\u201374. https:\/\/doi.org\/10.1007\/bf02081999. (PubMed PMID: 4615073).","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"1578_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/bf00262630","volume":"6","author":"KB Menander-Huber","year":"1978","unstructured":"Menander-Huber KB, Edsmyr F, Huber W. Orgotein (superoxide dismutase): a drug for the amelioration of radiation-induced side effects. A double-blind, placebo-controlled study in patients with bladder tumours. Urol Res. 1978;6(4):255\u20137. https:\/\/doi.org\/10.1007\/bf00262630. (PubMed PMID: 105443).","journal-title":"Urol Res"},{"issue":"2","key":"1578_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/02841868709091748","volume":"26","author":"OS Nielsen","year":"1987","unstructured":"Nielsen OS, Overgaard J, Overgaard M, Steenholdt S, Jakobsen A, Sell A. Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect. Acta Oncol. 1987;26(2):101\u20134. https:\/\/doi.org\/10.3109\/02841868709091748. (PubMed PMID: 2955799).","journal-title":"Acta Oncol"},{"issue":"4a","key":"1578_CR36","first-page":"2025","volume":"16","author":"F Sanchiz","year":"1996","unstructured":"Sanchiz F, Mill\u00e1 A, Artola N, Juli\u00e0 JC, Moya LM, Pedro A, et al. Prevention of radioinduced cystitis by orgotein: a randomized study. Anticancer Res. 1996;16(4a):2025\u20138 (PubMed PMID: 8712737).","journal-title":"Anticancer Res"},{"issue":"3","key":"1578_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ijrobp.2024.04.070","volume":"120","author":"J Zhu","year":"2024","unstructured":"Zhu J, Li X, Huang M, Zhu H, Tan Y, He X, et al. Application of recombinant human superoxide dismutase in radical concurrent chemoradiotherapy for cervical cancer to prevent and treat radiation-induced acute rectal injury: a multicenter, randomized, open-label, prospective trial. Int J Radiat Oncol Biol Phys. 2024;120(3):720\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.04.070. (Epub 20240504. PubMed PMID: 38705489).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1578_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14020231","volume":"14","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhu H, Zhang J. Oxidative stress on the ground and in the microgravity environment: pathophysiological effects and treatment. Antioxidants. 2025;14(2):231. https:\/\/doi.org\/10.3390\/antiox14020231. (Epub 20250218. PubMed PMID: 40002415; PubMed Central PMCID: PMCPMC11852023).","journal-title":"Antioxidants"},{"issue":"1","key":"1578_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-024-05030-1","volume":"19","author":"N Wang","year":"2024","unstructured":"Wang N, Zuo Z, Meng T, Liu Y, Zheng X, Ma Y. Salidroside alleviates simulated microgravity-induced bone loss by activating the Nrf2\/HO-1 pathway. J Orthop Surg Res. 2024;19(1):531. https:\/\/doi.org\/10.1186\/s13018-024-05030-1. (Epub20240902. PubMed PMID: 39218922; PubMed Central PMCID: PMCPMC11367893).","journal-title":"J Orthop Surg Res"},{"key":"1578_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22169088","author":"A Kumar","year":"2021","unstructured":"Kumar A, Tahimic CGT, Almeida EAC, Globus RK. Spaceflight modulates the expression of key oxidative stress and cell cycle related genes in heart. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22169088. (Epub20210823. PubMed PMID: 34445793; PubMed Central PMCID: PMCPMC8396460).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1578_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41526-021-00141-z","volume":"7","author":"C Ludtka","year":"2021","unstructured":"Ludtka C, Silberman J, Moore E, Allen JB. Macrophages in microgravity: the impact of space on immune cells. NPJ Microgravity. 2021;7(1):13. https:\/\/doi.org\/10.1038\/s41526-021-00141-z. (Epub 20210331 PubMed PMID: 33790288; PubMed Central PMCID: PMCPMC8012370).","journal-title":"NPJ Microgravity"},{"key":"1578_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311135","author":"LT Wesolowski","year":"2023","unstructured":"Wesolowski LT, Simons JL, Semanchik PL, Othman MA, Kim JH, Lawler JM, et al. The impact of SRT2104 on skeletal muscle mitochondrial function, redox biology, and loss of muscle mass in hindlimb unloaded rats. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241311135. (Epub 20230706. PubMed PMID: 37446313; PubMed Central PMCID: PMCPMC10342025).","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01578-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01578-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01578-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:31:05Z","timestamp":1767886265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01578-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1578"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01578-1","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was funded by the Austrian Research Promotion Agency (FFG); Project number #881646.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The study sponsor was the company SCARLETRED Holding GmbH. H.S. is the founder of the company and the inventor of the Scarletred\u00ae technology and declares no conflicts of interest pertaining to this publication. R.P. provided financially compensated consulting services for SCARLETRED Holding GmbH. B.V. is employed at Polymun Scientific Immunbiologische Forschung and declares no conflicts of interest pertaining to this publication. D.K. is the CEO of Polymun Scientific Immunbiologische Forschung and declares no conflicts of interest pertaining to this publication. M.Z. is an Editorial Board member of Clinical Pharmacokinetics. M.Z. was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and the Good Clinical Practice Guidelines of the International Conference on Harmonization. The Ethics Committee of the Medical University of Vienna and the Austrian Agency for Health and Food Safety approved the study, and it was registered under the EudraCT number 2022-000173-11.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"After providing oral and written informed consent to participate in the study, the healthy volunteers were assessed for eligibility according to the inclusion and exclusion criteria.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Data supporting the results reported in the article are not available publicly However, data can be provided on request from the authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"V.J., R.P., H.S., and M.Z. wrote the manuscript; M.B., R.P., B.V., D.K., R.B., H.S., and M.Z. designed the research; V.J., M.B., A.J., F.B., and M.WD. performed the research; V.J. analyzed the data; V.J., M.B., A.J., F.B., M.WD, R.P., B.V., D.K., R.B., H.S., and M.Z critically revised the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"The noncompartmental analysis was performed using Phoenix WinNonlin (Certara, Princeton, NJ, USA; version X.X). This software is commercially licensed, and its source code is not publicly available. However, all analysis settings and parameters used in this study are available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}